SLSeok Bum Lee

Seok Bum Lee

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Seok Bum Lee has a total of 113 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Criteria-based probable REM sleep behaviour disorder and risk of Lewy body dementia: analyses of a memory clinic cohort and a community cohort

    by Ji Won Han, Dae Jong Oh, Yu Jung Choi, Tae Hui Kim, Kyung Phil Kwak, Bong Jo Kim, Shin Gyeom Kim, Jeong Lan Kim, Seok Woo Moon, Joon Hyuk Park, et al.

    Background: REM sleep behaviour disorder (RBD) is the strongest prodromal marker of alpha-synucleinopathies, but whether a brief questionnaire carries prognostic information for Lewy body dementia is unclear. We tested whether criteria-based probable RBD (pRBD)—a questionnaire algorithm requiring both core clinical features specified in the International Classification of Sleep Disorders, Third Edition (ICSD-3)—shows a subtype-specific association pattern, defined as an association with incident Lewy body dementia (LBD; dementia with Lewy bodies [DLB] or Parkinson’s disease dementia [PDD]) but not with all-cause dementia. Methods: Retrospective analysis of prospectively collected data from two independent cohorts—a memory clinic cohort ( n = 619; median follow-up 3.4 years) and the community-based Korean Longitudinal Study on Cognitive Aging and Dementia (KLOSCAD; n = 5274; 6.4 years). Criteria-based pRBD required dream-enactment behaviour (RBD Screening Questionnaire item 3) plus at least one complex nocturnal motor behaviour (items 6.1–6.3). Cause-specific hazard models estimated associations with incident LBD (clinic) and all-cause dementia (KLOSCAD), with the competing dementia subtype or death as competing events. Sensitivity analyses included inverse probability of censoring weighting, interval-censoring imputation and Firth-penalised estimation. Results: In the memory clinic, 34 of 619 patients (5.5%) screened positive, of whom 5 (14.7%) developed LBD compared with 21 of 585 (3.6%) who screened negative (cause-specific hazard ratio [HR] 4.82, 95% CI: 1.54–15.10); there was no association with all-cause dementia (HR 1.00, 95% CI: 0.57–1.76). Of the 26 LBD events, 23 were DLB and 3 were PDD. In KLOSCAD, pRBD was not associated with all-cause dementia (HR 0.92, 95% CI: 0.47–1.81). An exploratory KLOSCAD analysis based on only nine LBD events (6 DLB, 3 PDD) produced a large but very imprecise estimate (HR 8.99, 95% CI: 1.71–47.17) that is hypothesis-generating rather than replication. Conclusions: In memory clinic patients, criteria-based pRBD was associated with incident LBD but not with all-cause dementia. The community cohort showed no all-cause association. This subtype-specific profile supports further evaluation of the screen for prioritising alpha-synucleinopathy assessment, pending validation with polysomnography-confirmed RBD. These findings rest on 26 events in a cohort in which only a minority of registered patients returned, and require confirmation.

  • Open Access

    Nanoparticle-enriched mass spectrometry enables comprehensive plasma proteomics and reveals novel candidates for mild cognitive impairment

    by Jin-Ho Kim, Oh Kwang Kwon, Won-Cheoul Jang, Hoi Keun Jeong, Kyung-Jin Lee, Changmi Oh, Kyung Mee Lee, Kyung-Hwa Choi, Xue Han, Seung Joon Lee, et al.

    Mild cognitive impairment (MCI) is a precursor to Alzheimer’s disease (AD), underscoring the need for reliable biomarkers for early identification. Here, we employed an automated nanoparticle-enrichment sample preparation platform combined with liquid chromatography–tandem mass spectrometry (LC–MS/MS) to facilitate comprehensive and unbiased detection of low-abundance proteins (LAPs). Through profiling of plasma proteomes from 42 individuals with MCI and 13 cognitively normal controls (NC), we identified 35 differentially expressed proteins (DEPs), of which four prioritized candidates were significantly correlated with Mini-Mental State Examination (MMSE) scores. Composite panels of candidate proteins showed potential to discriminate MCI, APOE4-carrier MCI, and amnestic MCI subtypes cases from NC, potentially providing insight into pathophysiological mechanisms underlying cognitive impairment. These findings highlight novel blood-based protein candidates uncovered by overcoming key limitations of conventional plasma proteomics, with potential to support MCI diagnosis.

  • Open Access

    Revisiting the Geriatric Depression Scale: An IRT-Based 10-Item Screen Outperforms the GDS-15 in Diagnostic Accuracy and Efficiency

    by Ji Won Han, Dae Jong Oh, Tae Hui Kim, Kyung Phil Kwak, Bong Jo Kim, Shin Gyeom Kim, Jeong Lan Kim, Seok Woo Moon, Joon Hyuk Park, Seung-Ho Ryu, et al.

    Background/Objective: Existing abbreviated Geriatric Depression Scales (GDSs), derived via Classical Test Theory (CTT), often sacrifice accuracy for brevity and retain non-specific items. We aimed to develop a minimum-item GDS maintaining diagnostic performance equivalent to the full 30-item scale (GDS30) using Item Response Theory (IRT). Methods: This cross-sectional study employed rigorous 5:5 split-sample cross-validation. Participants included 6525 older adults (aged ≥60 years) from community-based (Korean Longitudinal Study on Cognitive Aging and Dementia) and clinical settings (geropsychiatry clinic). Depression was diagnosed through standardized clinical interviews based on DSM-IV criteria. Two-parameter logistic IRT models estimated item discrimination and difficulty parameters. Sequential item reduction with DeLong tests identified the minimum number of items required to maintain GDS30-equivalent area under the curve (AUC). Results: The 10-item IRT-optimized scale (GDS10-IRT) achieved an AUC of 0.856 (95% CI: 0.809–0.895) in the validation set, showing no significant difference from GDS30 (AUC = 0.883; p = 0.396). Conversely, the 15-item GDS (GDS15) demonstrated significantly lower AUC than GDS30 (p < 0.001) despite having more items. GDS10-IRT achieved a 234% improvement in efficiency ratio (AUC/items) over GDS30. Notably, Item 16 (“feeling downhearted and blue”), identified as the most discriminating symptom (a = 2.53), is absent from the GDS15 but included in GDS10-IRT. Conclusions: IRT-based item selection achieves GDS30-equivalent diagnostic accuracy with only 10 items, outperforming the widely used GDS15. By recovering high-discrimination items excluded by CTT, the GDS10-IRT offers a more efficient, specific screening tool for late-life depression.

  • Open Access

    Revisiting the Geriatric Depression Scale: An IRT-Based 10-Item Screen Outperforms the GDS-15 in Diagnostic Accuracy and Efficiency

    by Ji Won Han, Dae Jong Oh, Tae Hui Kim, Kyung Phil Kwak, Bong Jo Kim, Shin Gyeom Kim, Jeong Lan Kim, Seok Woo Moon, Joon Hyuk Park, Seung-Ho Ryu, et al.

    Background/Objective: Existing abbreviated Geriatric Depression Scales (GDS), derived via Classical Test Theory (CTT), often sacrifice accuracy for brevity and retain non-specific items. We aimed to develop a minimum-item GDS maintaining diagnostic performance equivalent to the full 30-item scale (GDS30) using Item Response Theory (IRT). Methods: This cross-sectional study employed rigorous 5:5 split-sample cross-validation. Participants included 6,525 older adults (aged ≥60 years) from community-based (Korean Longitudinal Study on Cognitive Aging and Dementia) and clinical settings (geropsychiatry clinic). Depression was diagnosed through standardized clinical interviews based on DSM-IV criteria. Two-parameter logistic IRT models estimated item discrimination and difficulty parameters. Sequential item reduction with DeLong tests identified the minimum number of items required to maintain GDS30-equivalent area under the curve (AUC). Results: The 10-item IRT-optimized scale (GDS10-IRT) achieved an AUC of 0.856 (95% CI: 0.809–0.895) in the validation set, showing no significant difference from GDS30 (AUC=0.883; p=0.396). Conversely, the 15-item GDS (GDS15) demonstrated significantly lower AUC than GDS30 (p< 0.001) despite having more items. GDS10-IRT achieved a 234% improvement in efficiency ratio (AUC/items) over GDS30. Notably, Item 16 ("feeling downhearted and blue"), identified as the most discriminating symptom (a=2.53), is absent from the GDS15 but included in GDS10-IRT. Conclusion: IRT-based item selection achieves GDS30-equivalent diagnostic accuracy with only 10 items, outperforming the widely used GDS15. By recovering high-discrimination items excluded by CTT, the GDS10-IRT offers a more efficient, specific screening tool for late-life depression.

  • Open Access

    Evaluation of Activities of Daily Living: Current Insights and Future Horizons

    by Jin-Ho Kim, Seok Bum Lee

    Activities of daily living (ADL) assessments are crucial for evaluating functional independence and formulating care strategies for older adults. However, the existing tools encounter challenges, including cultural bias, subjectivity, and limited sensitivity to subtle changes in functional abilities. This review examines these limitations across basic, instrumental, and extended ADL categories and explores the integration of emerging technologies, such as artificial intelligence, sensor-based systems, and remote monitoring tools, to address these gaps. Technological advancements have the potential to enhance the accuracy, efficiency, and inclusivity of ADL assessment by providing objective data, supporting real-time evaluations, and enabling personalized care plans. By bridging the gap between traditional methods and innovative technologies, this review highlights a pathway for more equitable and effective assessments, ensuring that older adults across diverse contexts receive tailored support to maintain their independence and improve their quality of life.


  • A sleep-based risk model for predicting dementia: Development and validation in a Korean cohort

    by Hyukjun Lee, Ji Won Han, Seung Wan Suh, Hee Won Yang, Dae Jong Oh, Eunji Lim, Jin Shin, Bong Jo Kim, Dong Woo Lee, Jeong Lan Kim, et al.

    Background: Dementia is a major public health challenge, yet existing prediction models often overlook sleep-related symptoms, despite their known links to cognitive decline. Objective: To develop and validate a four-year Dementia Risk Score (DRS) incorporating self-reported sleep-related symptoms with demographic and clinical factors to predict all-cause dementia, including Alzheimer's disease. Methods: Data from 3082 Korean adults aged 60–79 years were analyzed. Predictors were selected using LASSO regression and included in a multivariate logistic regression model. A point-based scoring system, the DRS, was constructed from the model coefficients. Internal validation was conducted using bootstrapping and a separate dataset. Results: The DRS achieved robust predictive performance, with AUC values of 0.824 in the training set and 0.826 in the validation set. Key predictors included sleep disturbance, use of sleep medications, daytime dysfunction, leg discomfort, and urge to move legs. Conclusions: The DRS provides a practical, scalable tool for predicting dementia risk, supporting community-based screening and early intervention. External validation is needed to confirm its broader applicability.


  • Open Access

    Refining Western Dementia-Risk Paradigms: Evidence From a Decade of the Korean Longitudinal Study on Cognitive Aging and Dementia

    by Ji Won Han, Dae Jong Oh, Tae Hui Kim, Kyung Phil Kwak, Bong Jo Kim, Shin Gyeom Kim, Jeong Lan Kim, Seok Woo Moon, Joon Hyuk Park, Seung-Ho Ryu, et al.

    Han JW, et al. J Korean Med Sci. 2025 Nov;40(45):e326. https://doi.org/10.3346/jkms.2025.40.e326


  • Open Access

    Masticatory Function, Sex, and Risk of Dementia Among Older Adults: A Population-Based Cohort Study

    by Dae Jong Oh, Ji Won Han, Jun Sung Kim, Tae Hui Kim, Kyung Phil Kwak, Bong Jo Kim, Shin Gyeom Kim, Jeong Lan Kim, Seok Woo Moon, Joon Hyuk Park, et al.

    Oh DJ, et al. J Korean Med Sci. 2024 Jul;39:e246. https://doi.org/10.3346/jkms.2024.39.e246


  • Effects of Group Reminiscence Therapy Based on Korean Traditional Play for Mild Cognitive Impairment and Dementia Patients

    by Woo Youn Jung, Seul Gi Koo, Young Ju Kim, Seong-A Lee, Hyu Seok Jeong, Do Hyun Kim, Kyung Min Kim, Jung Jae Lee, Seok Bum Lee, Korean Association For Geriatric Psychiatry

    Objective: This study explored the efficacy of group reminiscence therapy, incorporating traditional plays, for individuals with mild cognitive impairment (MCI) and dementia patients. Methods: We provided 10 sessions of group reminiscence therapy to 25 MCI and dementia patients. We conducted assessments, both before and after the program, encompassing a range of tests, namely the Mini-Mental Status Examination (MMSE), Dysexecutive Questionnaire, Zarit Burden Interview (ZBI-K), Dementia Care Assessment Packet-Instrumental Activities of Daily Living, Geriatric Depression Scale (GDS-K), and Neuropsychiatric Inventory (NPI-K). Results: Following the program, there was a significant improvement in MMSE scores for MCI patients (19.17 to 22.33, p=0.027). There was a significant improvement in NPI-K scores for dementia patients (8.05 to 3.74, p=0.006). There was a significant improvement in GDS-K scores for MCI patients (17.00 to 14.00, p=0.043). There was a significant improvement in ZBIK scores for dementia (28.53 to 17.68, p=0.001) and MCI patients (29.17 to 16.33, p=0.046). Conclusion: Our study suggested that group reminiscence therapy based on traditional play might be effective in global cognition of MCI patients, neuropsychological symptoms of dementia patients, depression of MCI patients, and caregiver burden of all subjects.

  • Open Access

    A Preliminary Study on the Potential Protective Role of the Antioxidative Stress Markers of Cognitive Impairment: Glutathione and Glutathione Reductase

    by Sang-A Park, Gihwan Byeon, Jin Hyeong Jhoo, Hyung-Chun Kim, Myoung-Nam Lim, Jae-Won Jang, Jong Bin Bae, Ji Won Han, Tae Hui Kim, Kyung Phil Kwak, et al.

    Sang-a Park, Gihwan Byeon, Jin Hyeong Jhoo, Hyung-Chun Kim, Myoung-Nam Lim, Jae-Won Jang, Jong Bin Bae, Ji Won Han, Tae Hui Kim, Kyung Phil Kwak, Bong Jo Kim, Shin Gyeom Kim, Jeong Lan Kim, Seok Woo Moon, Joon Hyuk Park, Seung-Ho Ryu, Jong Chul Youn, Dong Woo Lee, Seok Bum Lee, Jung Jae Lee, Dong Young Lee, Ki Woong Kim. Clin Psychopharmacol Neurosci -0001;0:. https://doi.org/10.9758/cpn.23.1053